Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Abeona Therapeutics (ABEO) over the last 12 years, with Q3 2025 value amounting to $129000.0.

  • Abeona Therapeutics' Non Operating Income fell 1103.45% to $129000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 3718.12%. This contributed to the annual value of $1.2 million for FY2024, which is 5942.92% down from last year.
  • According to the latest figures from Q3 2025, Abeona Therapeutics' Non Operating Income is $129000.0, which was down 1103.45% from $89000.0 recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Non Operating Income high stood at $2.2 million for Q2 2023, and its period low was -$118000.0 during Q2 2022.
  • For the 4-year period, Abeona Therapeutics' Non Operating Income averaged around $331142.9, with its median value being $153500.0 (2024).
  • As far as peak fluctuations go, Abeona Therapeutics' Non Operating Income skyrocketed by 197711.86% in 2023, and later tumbled by 8988.71% in 2024.
  • Over the past 4 years, Abeona Therapeutics' Non Operating Income (Quarter) stood at $277000.0 in 2022, then dropped by 22.74% to $214000.0 in 2023, then surged by 209.81% to $663000.0 in 2024, then tumbled by 80.54% to $129000.0 in 2025.
  • Its Non Operating Income was $129000.0 in Q3 2025, compared to $89000.0 in Q2 2025 and $141000.0 in Q1 2025.